MERCK KGAA O.N. | 104.00 / +0.63% |
Date/Time | 12/05 / 17:35 |
Chg. / Chg.(%) | 0.65 / +0.63% |
Bid | - |
Ask | - |
Open | 103.80 |
Previous Close | 103.35 |
High | 104.70 |
Low | 103.35 |
Volume [EUR] | 63,446,092.05 |
Volume [Units] | 609,950 |
Price fixings | 2066 |
ISIN | DE0006599905 |
Security | MRK |
Exchange | Xetra |
Type | Stock |
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 104.00 | ![]() |
609,950 |
Cboe Europe .. | 104.20 | ![]() |
112,852 |
Turquoise | 104.20 | ![]() |
82,549 |
Cboe Europe .. | 104.20 | ![]() |
64,778 |
London Inter.. | 104.00 | ![]() |
22,735 |
TradeGate | 104.700 | ![]() |
5,203 |
Stuttgart | 104.350 | ![]() |
2,240 |
München | 104.05 | ![]() |
166 |
Frankfurt | 104.2000 | ![]() |
160 |
Borsa Italia.. | 103.95 | ![]() |
140 |
Vienna Globa.. | 104.20 | ![]() |
0 |
Hamburg | 103.35 | ![]() |
0 |
Düsseldorf | 104.20 | ![]() |
0 |
Hannover | 103.35 | ![]() |
0 |
Berlin | 104.00 | ![]() |
0 |
Lang & Schwa.. | 104.200 | ![]() |
|
gettex | 104.050 | ![]() |
|
Nasdaq Other.. | 113.6500 | 500 | |
SIX Swiss Ex.. | 102.20 | ||
SIX Swiss Ex.. | 97.00 | ||
EUREX | Options |
News
- RenovaCare Stockholder Update and 2020 Outlook from the CEO
14:30 - GlobeNewswire - Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update
11/12/2019 / 14:00 - GlobeNewswire - Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
11/09/2019 / 14:02 - GlobeNewswire - Merck says Q3 sales jump 12% YoY to $12.4B
10/29/2019 / 11:49 - TeleTrader - Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer in Podium and Poster Presentations at the Fifth International Cancer lmmunotherapy Conference in Paris, France
09/27/2019 / 12:05 - GlobeNewswire